More than 60 million Americans battle insomnia, and counting sheep, reading dull books or skipping naps isn't helping. Here ...

Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...

A sleep study can show how severe sleep apnea is and help determine the best course of treatment. People can discuss the potential benefits and risks of a mouthguard with their doctor. If they opt ...

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

“They also have increased prevalence of sleep apnea, hence evaluating markers of brain health such as the one mentioned serve as a way to understand early markers of disease risk for Alzheimer ...

“This is the first pharmacologic therapy that can treat obstructive sleep apnea in this way,” says Dan Skovronsky, chief scientific officer at Eli Lilly. Read More: Is Intermittent Fasting ...